Cargando…

Lixisenatide Reduces Chylomicron Triacylglycerol by Increased Clearance

CONTEXT: Glucagon-like peptide-1 (GLP-1) agonists control postprandial glucose and lipid excursion in type 2 diabetes; however, the mechanisms are unclear. OBJECTIVE: To determine the mechanisms of postprandial lipid and glucose control with lixisenatide (GLP-1 analog) in type 2 diabetes. DESIGN: Ra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whyte, Martin B, Shojaee-Moradie, Fariba, Sharaf, Sharaf E, Jackson, Nicola C, Fielding, Barbara, Hovorka, Roman, Mendis, Jeewaka, Russell-Jones, David, Umpleby, A Margot
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2018
Materias:	Clinical Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300412/ https://www.ncbi.nlm.nih.gov/pubmed/30215735 http://dx.doi.org/10.1210/jc.2018-01176

Ejemplares similares

Prandial Hypertriglyceridemia in Metabolic Syndrome Is Due to an Overproduction of Both Chylomicron and VLDL Triacylglycerol
por: Shojaee-Moradie, Fariba, et al.
Publicado: (2013)

The Effect of Fructose Feeding on Intestinal Triacylglycerol Production and De Novo Fatty Acid Synthesis in Humans
por: Steenson, Simon, et al.
Publicado: (2020)

Impact of liver fat on the differential partitioning of hepatic triacylglycerol into VLDL subclasses on high and low sugar diets
por: Umpleby, A. Margot, et al.
Publicado: (2017)

Insulin Detemir Reduces Weight Gain as a Result of Reduced Food Intake in Patients With Type 1 Diabetes
por: Zachariah, Sunil, et al.
Publicado: (2011)

Exploring the determinants of ethnic differences in insulin clearance between men of Black African and White European ethnicity
por: Ladwa, Meera, et al.
Publicado: (2021)

The fat mass and obesity-associated (FTO) gene allele rs9939609 and glucose tolerance, hepatic and total insulin sensitivity, in adults with obesity
por: de Soysa, Ann Kristin Hjelle, et al.
Publicado: (2021)

Defective Chylomicron Synthesis as a Cause of Delayed Particle Clearance in Diabetes?
por: Phillips, Catherine, et al.
Publicado: (2002)

Foam Cells Control Mycobacterium tuberculosis Infection
por: Agarwal, Pooja, et al.
Publicado: (2020)

Corrigendum: Foam Cells Control Mycobacterium tuberculosis Infection
por: Agarwal, Pooja, et al.
Publicado: (2020)

Metformin increases fasting glucose clearance and endogenous glucose production in non-diabetic individuals
por: McCreight, Laura J., et al.
Publicado: (2019)

The Chylomicron: Relationship to Atherosclerosis
por: Tomkin, Gerald H., et al.
Publicado: (2012)

Ethnic differences in beta cell function occur independently of insulin sensitivity and pancreatic fat in black and white men
por: Ladwa, Meera, et al.
Publicado: (2021)

Admission plasma potassium and length of hospital stay: a meta-analysis
por: Logan Ellis, Hugh, et al.
Publicado: (2023)

Black African men with early type 2 diabetes have similar muscle, liver and adipose tissue insulin sensitivity to white European men despite lower visceral fat
por: Bello, Oluwatoyosi, et al.
Publicado: (2019)

Erratum: Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study
por: Hodson, L, et al.
Publicado: (2017)

Docosahexaenoic acid enrichment in NAFLD is associated with improvements in hepatic metabolism and hepatic insulin sensitivity: a pilot study
por: Hodson, L, et al.
Publicado: (2017)

SEPARATION AND CHARACTERIZATION OF HUMAN SERUM CHYLOMICRONS
por: Scanu, Angelo, et al.
Publicado: (1959)

EFFECTS OF LIPOPROTEIN LIPASE ON THE STRUCTURE OF CHYLOMICRONS
por: Blanchette-Mackie, E. Joan, et al.
Publicado: (1973)

Role of the Enterocyte in Fructose-Induced Hypertriglyceridaemia
por: Steenson, Simon, et al.
Publicado: (2017)

Influence of chylomicron remnants on human monocyte activation in vitro
por: Bentley, C., et al.
Publicado: (2011)

Lixisenatide as add-on therapy to basal insulin
por: Brown, Dominique Xavier, et al.
Publicado: (2013)

Chylomicrons stimulate incretin secretion in mouse and human cells
por: Psichas, Arianna, et al.
Publicado: (2017)

Regulation of Chylomicron Secretion: Focus on Post-Assembly Mechanisms
por: Xiao, Changting, et al.
Publicado: (2018)

Low incidence of gastrointestinal adverse events over time with a fixed‐ratio combination of insulin glargine and lixisenatide versus lixisenatide alone
por: Trujillo, Jennifer M., et al.
Publicado: (2018)

Carboxylesterase1/Esterase-x Regulates Chylomicron Production in Mice
por: Quiroga, Ariel D., et al.
Publicado: (2012)

Removal of Chylomicron Remnants from the Bloodstream is Delayed in Aged Subjects
por: Vinagre, Carmen G, et al.
Publicado: (2018)

Effect of Nutrient and Micronutrient Intake on Chylomicron Production and Postprandial Lipemia
por: Desmarchelier, Charles, et al.
Publicado: (2019)

Chylomicron Retention Disease: Failure to Thrive and Abdominal Distention in an Infant
por: Nayak, Krisha, et al.
Publicado: (2021)

Temporal subsidence patterns of cemented polished taper-slip stems: a systematic review
por: Baryeh, Kwaku, et al.
Publicado: (2021)

Austrian Experience with Lixisenatide Under Real-Life Conditions: A Prospective Observational Study
por: Brath, Helmut, et al.
Publicado: (2019)

Lixisenatide in type 1 diabetes: A randomised control trial of the effect of lixisenatide on post‐meal glucose excursions and glucagon in type 1 diabetes patients
por: Ballav, Chitrabhanu, et al.
Publicado: (2020)

The effect of heparin clearing on the removal of chylomicron lipids from the living cornea.
por: Waters, L. L.
Publicado: (1968)

The Oxidative State of Chylomicron Remnants Influences Their Modulation of Human Monocyte Activation
por: Armengol Lopez, Sandra, et al.
Publicado: (2012)

The GTPase ARFRP1 controls the lipidation of chylomicrons in the Golgi of the intestinal epithelium
por: Jaschke, Alexander, et al.
Publicado: (2012)

Trans-Golgi proteins participate in the control of lipid droplet and chylomicron formation
por: Hesse, Deike, et al.
Publicado: (2012)

Intestinal SEC16B modulates obesity by regulating chylomicron metabolism
por: Shi, Ruicheng, et al.
Publicado: (2023)

Long Term Real-World Outcomes of Trifluridine/Tipiracil in Metastatic Colorectal Cancer—A Single UK Centre Experience
por: Tong, Daniel, et al.
Publicado: (2021)

Lixisenatide reduces postprandial hyperglycaemia via gastrostatic and insulinotropic effects
por: Becker, Reinhard H. A., et al.
Publicado: (2015)

Simultaneous Versus Sequential Initiation of Lixisenatide and Basal Insulin for Type 2 Diabetes: Subgroup Analysis of a Japanese Post-Marketing Surveillance Study of Lixisenatide (PRANDIAL)
por: Kaneto, Hideaki, et al.
Publicado: (2022)

Effect of Glycemic Control on Chylomicron Metabolism and Correlation between Postprandial Metabolism of Plasma Glucose and Chylomicron in Patients with Type 2 Diabetes Treated with Basal-bolus Insulin Therapy with or without Vildagliptin
por: Okajima, Fumitaka, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_77nc20le0nhm4g7gbaqq6h9bbg